Cubist Systematic Strategies’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$125K Buy
+111,512
New +$125K ﹤0.01% 1277
2025
Q1
Sell
-7,776
Closed -$12.8K 1724
2024
Q4
$12.8K Buy
+7,776
New +$12.8K ﹤0.01% 1386
2024
Q1
Sell
-214,345
Closed -$802K 2413
2023
Q4
$802K Buy
214,345
+179,543
+516% +$671K 0.01% 1201
2023
Q3
$73.8K Sell
34,802
-420,135
-92% -$891K ﹤0.01% 1664
2023
Q2
$2.17M Sell
454,937
-188,182
-29% -$896K 0.01% 849
2023
Q1
$3.67M Buy
643,119
+70,570
+12% +$402K 0.02% 775
2022
Q4
$5.78M Buy
572,549
+313,923
+121% +$3.17M 0.03% 588
2022
Q3
$5.8M Sell
258,626
-108,436
-30% -$2.43M 0.03% 708
2022
Q2
$9.1M Buy
367,062
+350,056
+2,058% +$8.67M 0.06% 402
2022
Q1
$659K Buy
17,006
+6,410
+60% +$248K 0.01% 2340
2021
Q4
$620K Sell
10,596
-70,438
-87% -$4.12M 0.01% 2289
2021
Q3
$4.8M Buy
81,034
+62,238
+331% +$3.69M 0.06% 486
2021
Q2
$1.63M Sell
18,796
-24,283
-56% -$2.11M 0.02% 1229
2021
Q1
$3.55M Sell
43,079
-28,281
-40% -$2.33M 0.05% 640
2020
Q4
$6.49M Sell
71,360
-15,112
-17% -$1.37M 0.09% 320
2020
Q3
$3.46M Buy
86,472
+86,372
+86,372% +$3.45M 0.05% 584
2020
Q2
$3K Buy
+100
New +$3K ﹤0.01% 2356
2020
Q1
Sell
-44,217
Closed -$865K 2241
2019
Q4
$865K Buy
44,217
+44,212
+884,240% +$865K 0.02% 1248
2019
Q3
$0 Sell
5
-4,943
-100% ﹤0.01% 2278
2019
Q2
$100K Buy
4,948
+2,086
+73% +$42.2K ﹤0.01% 2233
2019
Q1
$50K Sell
2,862
-18,403
-87% -$322K ﹤0.01% 2103
2018
Q4
$273K Buy
+21,265
New +$273K 0.01% 1348